Detalhe da pesquisa
1.
Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells.
J Virol
; 97(9): e0100523, 2023 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671865
2.
Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
J Virol
; 94(3)2020 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31694943
3.
Cell Cycle Arrest in G2/M Phase Enhances Replication of Interferon-Sensitive Cytoplasmic RNA Viruses via Inhibition of Antiviral Gene Expression.
J Virol
; 93(4)2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30487274
4.
Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus.
J Virol
; 91(16)2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566376
5.
Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.
J Gen Virol
; 98(12): 2895-2911, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29143726
6.
Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.
J Virol
; 87(18): 10283-94, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23864625
7.
Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.
J Virol
; 86(6): 3073-87, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22238308
8.
The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer.
J Surg Oncol
; 107(7): 713-22, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23335066
9.
Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.
J Gen Virol
; 93(Pt 12): 2529-2545, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23052398
10.
Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
Mol Ther Oncolytics
; 24: 59-76, 2022 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34977342
11.
Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions.
Cancers (Basel)
; 13(5)2021 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33803211
12.
RIG-I mediates nonsegmented negative-sense RNA virus-induced inflammatory immune responses of primary human astrocytes.
Glia
; 58(13): 1620-9, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20578054
13.
Identification of sendai virus L protein amino acid residues affecting viral mRNA cap methylation.
J Virol
; 83(4): 1669-81, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19052078
14.
Analysis of virion associated host proteins in vesicular stomatitis virus using a proteomics approach.
Virol J
; 6: 166, 2009 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-19821998
15.
Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy.
Mol Ther Oncolytics
; 5: 20-40, 2017 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28480326
16.
Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
Oncotarget
; 7(38): 61601-61618, 2016 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27533247
17.
Evolution of oncolytic viruses.
Curr Opin Virol
; 13: 1-5, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25699475
18.
Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1.
Virology
; 485: 340-54, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26331681
19.
Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.
Virology
; 474: 163-73, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25463614
20.
An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cells.
Virology
; 483: 126-40, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25965802